Disease | patent foramen ovale |
Symptom | C0149931|migraine |
Sentences | 11 |
PubMedID- 22720197 | Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up. |
PubMedID- 22199445 | Herein, we describe late complications after the transcatheter device closure of a patent foramen ovale in a patient with migraine headaches. |
PubMedID- 20854974 | patent foramen ovale (pfo) is associated with cryptogenic stroke, migraine headache, decompression sickness, and platypnea-orthodeoxia syndrome. |
PubMedID- 21450305 | patent foramen ovale in children with migraine headaches. |
PubMedID- 20231534 | Background: clinical observations of migraine headache symptoms in patients with a patent foramen ovale (pfo), both of which conditions are highly prevalent, have raised the question of a possible pathophysiological relationship. |
PubMedID- 22888208 | Background: right to left shunting, usually caused by a patent foramen ovale (pfo), is associated with migraine and visual aura. |
PubMedID- 23890906 | Association of migraine aura with patent foramen ovale and atrial septal aneurysms. |
PubMedID- 20199198 | migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation. |
PubMedID- 21827543 | Role of patent foramen ovale in migraine etiology and treatment: a review. |
PubMedID- 20819012 | migraine has been associated with patent foramen ovale (pfo), and pfo closure has become the most high-profile nonpharmacologic invasive therapy recommended for the prevention of recurrent migraine attacks, as well as for preventing further attacks in cryptogenic stroke. |
PubMedID- 26017514 | migraine with aura and patent foramen ovale: myth or reality. |
Page: 1